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Abstract
Calvarial bones form by direct ossification of mesenchyme. This requires condensation of mesenchymal cells which then proliferate and
differentiate into osteoblasts. Congenital hydrocephalus (ch) mutant mice lack the forkhead/winged helix transcription factor Foxc1. In ch
mutant mice, calvarial bones remain rudimentary at the sites of initial osteogenic condensations. In this study, we have localized the
ossification defect in ch mutants to the calvarial mesenchyme, which lacks the expression of transcription factors Msx2 and Alx4. This lack
of expression is associated with a reduction in the proliferation of osteoprogenitor cells. We have previously shown that BMP induces Msx2
in calvarial mesenchyme (Development 125, 1241–1251, 1998). Here, we show that BMP also induces Alx4 in this tissue. We also show
that BMP-induced expression of Msx2 and Alx4 requires Foxc1. We therefore suggest that Foxc1 regulates BMP-mediated osteoprogenitor
proliferation and that this regulation is required for the progression of osteogenesis beyond the initial condensations in calvarial bone
development.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
Bone formation is an essential part of skull vault (cal-
varial) development in vertebrates. Calvarial bones, which
are composed of two frontal, two parietal, and an interpa-
rietal bone, as well as most facial bones, form directly from
mesenchyme by intramembranous ossification. Osteogene-
sis in these bones starts by mesenchymal cell condensation.
These cells undergo differentiation into osteoprogenitor
cells, which proliferate and ultimately differentiate into os-
teoblasts that lay down the bone matrix (Hall and Miyake,
1992). The mesenchymal condensations of the frontal and
parietal bones form on the lateral aspects of the brain close
to the cranial base. The calvarial bones grow as sheets
between the brain and epidermis, and extend apically to-
ward the top of the skull (Rice et al., 2000). Osteoblast
differentiation occurs at the bone margins, or osteogenic
fronts, where osteoblasts invade into and progenitor cells
are recruited from the surrounding mesenchyme. Prior to
birth, calvarial bones approximate each other with sutures
forming between the bone margins. Sutures accommodate
brain growth. In mouse, all calvarial sutures, except for the
posterior section of the frontal suture, remain patent. In
humans, metopic/frontal suture is obliterated by the third
year, and others fuse in the third or fourth decade of life.
Calvarial bones form in a unique environment to other
bones; they form in close contact with dura mater, which is
the topmost layer of the meninges. Interactions between the
dural cells and calvarial mesenchyme have been shown to
be important in the regulation of calvarial bone develop-
ment (Opperman et al., 1995).
During recent years, the understanding of molecular
mechanisms involved in calvarial bone development has
increased considerably, and several genes regulating ossifi-
cation have been identified through analysis of mouse mu-
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Fig. 1. Expression of Foxc1 and Foxc2 in forming calvarial bones, cartilages, meninges, and mandible. (A–O) Analysis of Foxc1 and Foxc2 expression
pattern. (A–D) Expression of Foxc1 is intense in the condensing prechondrogenic mesenchyme (*) and the primitive meningial layers (arrowheads). (C)
Mesenchymal condensation of frontal bone has only minimal levels of Foxc1 expression (surrounded by dashed line), but calvarial mesenchyme (arrow)
between the brain and surface ectoderm is positive. (D) Later, Foxc1 transcripts are localized to osteoblasts and osteoblast-forming mesenchyme and the
meninges. (E–H) Foxc2 is not expressed in the calvarial osteogenic mesenchyme (arrows) but it is coexpressed with Foxc1 in the meninges. (I, J) Sagittal
suture between the opposing parietal bone margins. (I) Foxc1 is not expressed in the mesenchymal condensations of osteogenic fronts, while sutural
mesenchyme expresses Foxc1. (J) Fibroblast growth factor receptor 2 IIIc (Fgfr2c) expression was used as a marker for osteogenic condensations in the
suture (Rice et al., 2000). (K, L) Expression of Foxc2 in Foxc1/ animals. Foxc2 expression pattern is unchanged in the developing cartilages in ch mutants.
(L) The developing meninges appear to have reduced levels of Foxc2 transcripts in the lateral and dorsal regions at E15. This may be due to thin meningial
cell layers in Foxc1/ mutant embryos. b, brain; c, cranial base cartilage; e, eye; f, frontal bone; m, meninges; n, nasal cartilage; p, parietal bone; s, sutural
mesenchyme. (M) Foxc1 is expressed strongly in the osteoblasts of the mandible and in the perichondrium of Meckel’s cartilage. (N, O) Foxc2 is expressed
at lower levels in these tissues compared with Foxc1 both in wild type and Foxc1/ animals. Scale bars are 200 m.
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tants. Mice deficient for the Runt domain-containing tran-
scription factor Runx2 (previously Cbfa1) lack all bones,
including those of the skull vault (Otto et al., 1997). Runx2
is necessary for osteoblast differentiation, and in cell cul-
ture, it acts as an activator of osteoblast-specific gene ex-
pression. The homeobox transcription factor Msx2 has been
suggested to be an upstream regulator of Runx2 in osteo-
progenitor cells since Runx2 expression is downregulated in
Msx2-deficient mice (Satokata et al., 2000). Msx2 deficient
mice exhibit a delay in calvarial bone ossification and an
overall decrease in bone volume. Msx2 has a pivotal role in
mediating the balance between early osteoprogenitor cell
proliferation and differentiation in calvarial development
(Liu et al., 1999; Satokata el al., 2000) In humans, haplo-
insufficiency for MSX2 results in parietal foramina, which is
a skull ossification defect in parietal bones (Wilkie et al.,
2000; Wuyts et al., 2000a), whereas enhanced MSX2 gene
function causes premature suture fusion resulting in Boston
type craniosynostosis (Jabs et al., 1993; Ma et al., 1996).
Parietal foramina can also be caused by mutations in the
paired-type homeobox gene ALX4 (Wu et al., 2000; Wuyts
et al., 2000b; Mavrogiannis et al., 2001). In mice lacking
Alx4, the calvarial bone phenotype resembles that of Msx2
mutants; ossification is delayed and parietal bones do not
extend over the superior aspect of the skull in newborns (Qu
et al., 1997). In humans, heterozygous loss of TWIST causes
craniosynostosis, and in a subset of the affected individuals,
it can cause parietal foramina (Thompson et al., 1984).
We have used the congenital hydrocephalus (ch) mouse
line to study regulation of calvarial osteogenesis. This is a
spontaneous mouse mutant line originally described by
Gru¨neberg (1943). In ch mutant embryos, cartilages and
bones are affected throughout the body, but the major skel-
etal phenotype is the lack of calvarium associated with
hydrocephalus. Rudimentary calvarial bones form at the
sites of initial mesenchymal condensations but they fail to
extend cranially (Gru¨neberg, 1943, 1953; Green, 1970;
Kume et al., 1998; Hong et al., 1999). Other organs and
structures affected and studied in ch mutants include the
heart (Winnier et al., 1999), eye (Kume et al., 1998; Hong
et al., 1999; Kidson et al., 1999), urogenital organs (Green,
1970; Gru¨neberg and Wickramaratne, 1974; Kume et al.,
2000), and leptomeninges (Gru¨neberg and Wickramaratne,
1974; Kume et al., 1998). Congenital hydrocephalus is
caused by a point mutation in the forkhead/winged helix
transcription factor Foxc1 (previously Mf1) (Kume et al.,
1998; Hong et al., 1999). The point mutation results in a
stop codon at the amino terminus of the DNA-binding
winged helix domain, and thus ch mutant animals lack
functional Foxc1 protein. Mice with Foxc1 null alleles and
ch mutant mice have identical phenotypes (Kume et al.,
1998). The expression pattern of Foxc1 has been studied in
early embryogenesis (Sasaki and Hogan, 1993) as well as
during organogenesis, specifically during development of
the eye (Kume et al., 1998; Kidson et al., 1999), heart
(Swiderski et al., 1999; Winnier et al., 1999), kidney (Kume
et al., 2000), and endochondral skeleton (Kume et al.,
1998). Foxc1 is highly homologous to Foxc2, previously
Mfh1 (Hiemisch et al., 1998a). Studies of animals with
Foxc1 and Foxc2 single null alleles and double and com-
pound heterozygotes suggest that at least partial functional
redundancy between the two genes exists during embryo-
genesis (Winnier et al., 1999; Kume et al., 2000, 2001). Yet,
little is known about the function and downstream targets of
Foxc1.
In order to examine the function of Foxc1 in calvarial
bone development, we have examined the detailed expres-
sion pattern of Foxc1 and Foxc2 during calvarial develop-
ment and studied the pathogenesis of the calvarial pheno-
type in ch mutant mice. We show that ch mutant embryos
lack Msx2 and Alx4 expression in the osteogenic calvarial
mesenchyme, as well as Alx4 expression in the meninges.
Functional in vitro assays indicate that Foxc1 is required for
the induction of Msx2 and Alx4 by BMP in the osteogenic
Fig. 2. Osteogenesis does not progress beyond the initial condensation sites
in calvarial bones in Foxc1/ mutant embryos. (A) Wild type and
Foxc1/ littermate embryos. Mutant embryo shows the deformed head
with hydrocephalus and absence of skull bones. Scale bars are 1 mm. (B)
Analysis of bone in frontal head sections. Mineralized frontal bone is
visualized by Bone sialoprotein expression. Frontal bone growth
progresses superiorly in wild type animals, but in Foxc1/ animals, the
mineralized bone is limited to the initial mesenchymal condensation site.
Scale bars are 200 m.
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calvarial mesenchyme. In addition, we show that this mes-
enchymal cell population exhibits reduced proliferation in
ch mutants. Our results demonstrate that Foxc1 plays a
critical role in mediating the BMP signal that regulates
Msx2 and Alx4 expression and in the progression of osteo-
genesis during calvarial bone development.
Materials and methods
Mating and genotyping
Embryos were obtained by mating congenital hydro-
cephalus (ch) heterozygote mice (Jackson Laboratories,
USA). The vaginal plug date was designated as E0. To
detect the point mutation in the Foxc1 gene in ch mice
(Kume et al., 1998) solid-phase minisequencing was set up
to detect the variable nucleotide. A fragment of Foxc1
sequence surrounding the variable nucleotide in Foxc1 gene
was amplified from tail DNA samples by PCR. We used
GC-rich PCR system kit (Roche) according to the manufac-
turer’s protocol with the exception of using 10 p mol of
5-biotin-labeled reverse primer. Forward primer 5-CTAC-
CAGTTCATCATGGACCGC-3 and 5-biotinylated re-
verse primer 5-7CGAGCGTCCAGTAGCTGCCC-3 were
used. The PCR cycle was: 95°C for 3 min, 63°C for 1 min,
72°C for 1 min, and 95°C for 1 min. Cycle was repeated 33
times, and the final products were extended at 72°C for 8
min. The PCR products were used as a template for solid-
phase minisequencing as described in Suomalainen and
Syvanen (1996); detection primer 5- GGGACAATAAG-
CAGGGCTGG-3, 3H-labeled dCTP (53.0 Ci/mmol
specific activity; Amersham), and 3H-labeled TTP (118 Ci/
mmol specific activity; Amersham) were used. Radiola-
beled dCTP was incorporated onto the detection primer
bound to the wild type allele of Foxc1, and radiolabeled
TTP to the mutated allele. The amount of radiolabel was
measured in a scintillation counter (Wallac) using 3H count-
ing program. Counting the ratio of 3H-dCTP and 3H- TTP
between duplicate samples indicated the nucleotide present
at the variable site of the Foxc1 gene. If the 3H-dCTP/3H-
TTP ratio was 10, the genotype was wild type. A ratio
between 0.5 and 2 corresponded to a heterozygous, and a
ratio 0.1 corresponded to a mutant genotype.
Tissue dissection and culture
E15 calvaria were dissected from heads. Brains and ep-
ithelia were removed. After brain removal, the dura mater
was still attached to the mesenchyme of the explant. Ex-
plants were cultured on filters, supported by grids, in Dul-
becco’s minimal essential medium (DMEM). DMEM was
supplemented with GlutaMAX-1 (Life Technologies), 10%
FCS, 100 g/ml of ascorbic acid, and 20 IU/ml penicillin-
streptomycin. Explants were cultured at 37°C in 5% CO2 for
48 h.
Bead implantation assays
Affi-Gel blue agarose beads (100–200 m; Bio-Rad)
were incubated with 100 ng/l recombinant human BMP2
(R&D Systems) for 1 h at 37°C. Control beads were soaked
with the same concentration of bovine serum albumin under
the same conditions. Protein-containing beads were placed
on the top of the calvarial explants under a dissecting
microscope. Explants were cultured as described above, and
fixed in 4% paraformaldehyde overnight at 4°C.
Skeletal staining
E17 calvaria or E15 calvarial explants cultured for 7 days
were fixed in 95% ethanol overnight, and stained in alcian
blue staining solution (150 g/ml alcian blue, 80% ethanol,
and 20% acetic acid) overnight. Excess alcian blue was
removed in 95% ethanol. Tissues were cleared in 2% KOH
for 2 h before transfer into the alizarin red staining solution
(75 g/ml of alizarin red in 1% KOH) and incubated 4–15
h. Explants were cleared in 20% ethanol/1% KOH, and
transferred into glycerol–ethanol (1:1) solution, and stored
at 4°C. The shortest distance between the parietal bone
margins was measured as the minimum sagittal suture
width. Statistical analysis of the mean values was performed
by t test.
BrdU incorporation and TUNEL analysis
Pregnant ch heterozygote females were injected i.p. with
2 ml/100 g body weight of undiluted 5- bromo-2-deoxyuri-
dine (BrdU) solution (Zymed). After 2 h, embryos were
collected, fixed in Bouin’s fixative, and paraffin-embedded.
BrdU incorporation was immunodetected by using BrdU
staining kit (Zymed). BrdU-positive cells were counted in
the calvarial mesenchyme adjacent to the advancing osteo-
genic condensations, which were detected morphologically.
A minimum of 10 sections were analyzed per mouse. The
same size area of the calvarial mesenchyme was marked on
each section. Two independent observers performed cell
counting. Statistical analysis on average cell counts was
performed by t test. Terminal deoxynucleotidyl transferase-
mediated dUTP nick- end labeling (TUNEL) assay was
performed by using DeadEnd Colorimetric TUNEL System
(Promega).
35S in situ hybridization
In situ hybridization on tissue sections was performed as
described by Vainio et al. (1993). The preparation of the
following RNA probes has been described: Alx4 (Hudson et
al., 1998), Bsp (Rice et al., 1999), Fgfr2c (Rice et al., 2000),
Foxc1 (Hiemisch et al., 1998b), Msx1 and Msx2 (Jowett et
al., 1993). Foxc2 probe was a kind gift from Dr. Kirsi Sainio
(University of Helsinki). Both bright and dark field images
were taken from hybridized sections. Silver grains were
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selected from the dark field image, colored red, and super-
imposed onto the identical bright field image.
Results
Foxc1 and Foxc2 expression in the developing calvarium
We examined the expression pattern of Foxc1 and Foxc2
by in situ hybridization using frontal sections of the devel-
oping calvarium (Fig. 1). An early sign of intramembranous
bone development is the formation of mesenchymal con-
densations at E12 (Rice et al., 2000). We focused our
studies between E11 and E15, when mineralized bone is
formed. Some Foxc1 transcripts were localized in the cal-
varial mesenchyme already at E11 (Fig. 1A). From E12
onwards, the calvarial mesenchyme stretching across the
developing skull had a high level of Foxc1 expression (Fig.
1B–D). In contrast, Foxc1 expression was detected only at
a minimal level in the mesenchymal condensations of the
frontal bones at E13 (Fig. 1C). At E15, Foxc1 transcripts
were localized to mature osteoblasts and the periosteum in
the calvarial bones (Fig. 1D). At this stage, parietal bones
oppose each other at the top of the calvarium and form a
sagittal suture which comprises mesenchymal condensa-
tions at osteogenic fronts separated by sutural mesenchyme.
We detected only a low level of Foxc1 expression in these
condensations, while sutural mesenchyme showed intense
Foxc1 expression (Fig. 1I).
In the developing cartilages, the Foxc1 expression was
intense in prechondrogenic mesenchymal condensations of
the developing cranial base and nasal cartilages at E12 and
E13 (Fig. 1B and C). Later, the expression of Foxc1 was
limited to the perichondrium (Fig. 1D). In addition, Foxc1
was expressed strongly throughout meningeal development,
starting at E12.
Foxc1 and Foxc2 have been shown to have distinct but
overlapping expression patterns in many mesodermal tis-
sues (Hiemisch et al., 1998b). Foxc1 and Foxc2 showed
coexpression in prechondrogenic mesenchyme in the head
and in the developing meninges (Fig. 1B, C, F, and G).
Foxc2 transcripts were not detected in calvarial osteogenic
mesenchyme (Fig. 1G and H). In ch mutant mice, Foxc2
expression was essentially normal in the calvarial region
(Fig. 1K and L). At E15, meninges showed reduced expres-
sion of Foxc2 in dorsal and lateral areas. This may be due
to thin meningeal cell layers in the ch mutant (Kume et al.,
1998). In facial bones, for instance in the mandible, Foxc1
was expressed in osteoblasts and in the perichondrium of
Meckel’s cartilage, and Foxc2 transcripts were localized in
the same regions but at a reduced level (Fig. 1M–O).
Thus, the expression pattern of Foxc1 is consistent with
roles during early and late stages of bone formation. Foxc1
may have an early function in the head mesenchyme des-
tined to become skeletal structures, and a later role may be
to regulate osteoblast function. Interestingly, Foxc1 expres-
sion was turned off between these early and late stages
when mesenchymal cells aggregate and form osteogenic
condensations. Foxc1 and Foxc2 were coexpressed in the
jaw bones and in the dural cell layer but not in the calvarial
mesenchyme.
The calvarial phenotype of ch mutant mice is not
secondary to hydrocephalus and is apparent in ch
heterozygotes
In ch mutant embryos, the hydrocephalus was appar-
ent at E15 with brain tissue protruding anteriorly due to
expanded ventricles (Fig. 2A). The calvarial mesen-
chyme was thin and loosely organized. At this stage,
calvarial bone development was progressing toward the
apex of the skull in the wild type embryos, while in ch
mutants, mature osteoblasts were located only within the
area demarcated by the initial osteogenic mesenchymal
condensations seen at E13, and did not extend superiorly
(Fig. 2B). Bone growth was visualized by in situ hybrid-
ization with a probe for Bone sialoprotein, which is
expressed in functional osteoblasts, and by whole-mount
alizarin red/alcian blue staining of heads and calvarial
explants (Fig. 3A–F). Bone was missing from the apical
aspect of the skull in ch mutants; only rudimentary cal-
varial bones formed at the sites of initial osteogenic
condensations. These bones were misshapen with the
frontal and parietal bones extending posteriorly.
Although heterozygous ch embryos have been reported
to exhibit normal calvaria (Green, 1970), abnormalities in
their endochondral skeleton have been described (Green,
1970; Hong et al., 1999). Therefore, we analyzed the cal-
varial phenotype of heterozygous embryos in detail. We
measured the minimum width of the sagittal suture between
parietal bones in wild type and heterozygous calvarial ex-
plants at E17 (Fig. 3G and H). In wild type embryos, the
sagittal suture width ranged from 0.03 to 0.47 mm with the
mean being 0.23 mm (n  7; s.d.  0.14). In heterozygous
embryos, the minimum sagittal suture width ranged from
0.17 to 0.60 mm, the mean being 0.39 mm (n  7; s.d. 
0.14). Thus, the sagittal suture was 41% wider in heterozy-
gotes than in wild type littermates (P  0.03). Furthermore,
all seven heterozygous explants had an irregularly shaped
patch of secondary cartilage endocranial to the sagittal su-
ture mesenchyme, while only two out of seven wild type
explants (29%) had a similar but smaller secondary carti-
lage.
The failure of calvarial bone growth to progress in ch
mutant animals has been suggested to be secondary to the
hydrocephalus and caused by increased intracranial pres-
sure (Gru¨neberg, 1943; Kume et al., 1998). To test this,
we followed the development of E15 calvarial explants in
organ cultures for 7 days and then stained them for bone
and cartilage (Fig. 3I–N). In these conditions, the possi-
ble mechanical effects of intracranial pressure are elim-
inated. Calvarial bones increased in size in wild type
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Fig. 3. Calvarial bone development is inhibited in Foxc1/ animals and the inhibition is not secondary to hydrocephalus. (A–H) Skeletal staining of E17
heads and calvarial explants. Mineralized bone is stained with alizarin red and cartilages with alcian blue. (A–C) Lateral view of heads. The difference
between wild type and Foxc1/ calvarial development is not apparent, but the Foxc1/ animal lacks skull top. (D–F) Calvarial explants (two view) show
that wild type and Foxc1/ embryos have two frontal and two parietal bones, and an interparietal bone. In the Foxc1/ embryo, their growth has been
arrested. Note the mesenchymal tissue stretching across the skull top in the Foxc1/ calvarial explant (*). (G, H) High magnification images of the wild
type and Foxc1/ explants show that sagittal suture is wider in Foxc1/. (H) Secondary cartilage (arrow) has formed in Foxc1/ embryo endocranial
to the suture. (I–N) In vitro culture of E15 calvarial explants, top view. Seven day (t7) cultures show that elimination of the intracranial pressure did not rescue
the growth of the calvarial bones in Foxc1/ and Foxc1/ explants in comparison with t7 wild type cultures and day zero (t0) cultures. Images shown
are representative samples. f, frontal bone; ip, intraparietal bone; p, parietal bone. (Note that t0 and t7 explants are different since no skeletal staining can
be done during culture period.) Scale bars are 1 mm.
explants (n  3), and the sagittal suture became nar-
rower. In heterozygous explants (n  12), the sagittal
suture stayed wide in all explants. We did not observe
any bone growth in ch mutant explants (n  4), and the
calvarial mesenchyme between rudimentary calvarial
bones regressed in ch mutant explants. Hence, we did not
observe any rescue of bone growth in heterozygous or ch
mutant explants when cultured in vitro.
These data suggest that the arrested calvarial develop-
ment in ch mutants is not secondary to mechanical influ-
ences of the hydrocephalus, and that Foxc1 directly regu-
lates the growth of calvarial bones. Lack of one Foxc1 allele
is sufficient to cause a delay in the ossification of parietal
bone plates.
Msx2 and Alx4 expression are downregulated in calvarial
mesenchyme of Foxc1 mutant mice
We searched for potential downstream targets of Foxc1
by in situ hybridization analysis of ch mutant calvarial
tissue (Fig. 4). Runx2, a marker for preosteoblasts, is ex-
pressed in osteogenic condensations at E13, and also in the
preosteoblasts between the brain and epidermis at E15. The
expression pattern of Runx2 appeared normal in ch mutant
Fig. 4. The expression of Msx2 and Alx4 but not Msx1 is downregulated in the calvarial mesenchyme of Foxc1/ animals. Analysis of candidate
downstream target gene expression. Boxed areas in the first and third columns show the areas of the enlargements in second and fourth columns, respectively.
(A–F) At E15, Runx2 transcripts are limited to the initial condensation site in Foxc1/ embryo. (G–L) Msx2 expression is restricted in the Foxc1/
embryo to lateral head mesenchyme at E13 during calvarial development. (I, J) The superior extent of the expression of Msx2 is indicated by the arrow in
Foxc1/ embryo. (M–R) Msx1 is expressed throughout the head mesenchyme and the meninges both in wild type and Foxc1/ embryos. (S–X) Alx4
expression is limited in the osteogenic head mesenchyme as well as in the meninges in the Foxc1/ embryo. (U, V) The superior extent of Alx4 expression
is indicated by the arrow in Foxc1/ embryo. cp, choroid plexus. Scale bars are 200 m.
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animals at E13, but Runx2 transcripts were limited to re-
gions surrounding the rudimentary calvarial bones at E15,
and no transcripts were seen more superiorly in the calvarial
mesenchyme (Fig. 4A–F).
Msx2 null mice have defective skull ossification and a
persistent bone-free area between the parietal bones (Satokata
et al., 2000). Our previous work has shown that Msx2 is
expressed in sagittal suture mesenchyme and at the osteogenic
fronts of parietal bones that are active sites of osteoblast dif-
ferentiation (Kim et al., 1998). In wild type embryos, Msx2
was expressed throughout the calvarial osteogenic mesen-
chyme at E13 (Fig. 4G and H). In bone, Msx2 was expressed
in the periosteum (Fig. 4K). In ch mutant embryos, Msx2
expression was limited to the calvarial mesenchymal conden-
sations and a region extending a short distance into the osteo-
genic mesenchyme beyond the condensation sites. No expres-
sion was detected more superiorly in the osteogenic
mesenchyme (Fig. 4I and J). At E15, Msx2 expression was
further limited to the periosteum of the rudimentary bones (Fig.
4L). Other craniofacial structures exhibited a normal Msx2
expression pattern in ch mutant tissue.
Msx1, a gene related to Msx2, is expressed in a pattern
similar to Msx2 during calvarial development (MacKenzie
et al., 1991), and mice lacking Msx1 exhibit multiple cranio-
facial abnormalities (Satokata and Maas, 1994). In ch mu-
tant animals, the Msx1 expression pattern was unchanged
(Fig. 4M–R).
The Alx4 null mice have a localized bone defect in the skull,
and their calvarial phenotype is reminiscent of the Msx2 mu-
tant phenotype. Alx4 has been reported to be expressed in
osteoblastic precursor cells of most bones and in the develop-
ing meninges (Hudson et al., 1998). We detected Alx4 expres-
sion in condensations of calvarial bones, and in the osteogenic
mesenchyme in a pattern similar to that of Msx2 (Fig. 4S, T,
and W). In addition, Alx4 was expressed in the developing
meninges. In ch mutant embryos, Alx4 expression was detected
in the condensations of calvarial bones, but it was greatly
reduced in the calvarial mesenchyme similarly to Msx2 (Fig.
4U, V, and X) The meningeal expression of Alx4 was also
limited to inferior region in ch mutants. Other craniofacial
structures exhibited a normal expression pattern of Alx4.
Thus, ch mutant animals exhibit a location-specific lack
of Msx2 and Alx4 expression in the calvarial mesenchyme,
and in addition Alx4 was reduced in the meninges. It would
therefore appear that the failure of calvarial bone growth in
ch mutants is caused by a lack of expression of early
differentiation factors, such as Msx2 and Alx4, in the cal-
varial mesenchyme and the dura mater.
Foxc1 is required in the calvarial mesenchyme for the
induction of Msx2 and Alx4 by BMP
Bone morphogenetic proteins (BMPs) are signaling mol-
ecules that were discovered by their ability to induce ectopic
bone formation (Urist, 1997). Since Msx2 has been associ-
ated with BMP signaling (Kim et al., 1998), we analyzed the
expression patterns of Bmp2, 4, and 7 in frontal head
sections at E15. Although the expression of these Bmps has
been reported in these tissues at different stages, the precise
expression patterns in the calvarial mesenchyme and the
surrounding tissues have not been described. Bmp2, 4,
and 7 are expressed in the calvarial mesenchyme, and
Bmp4 and 7 also in the meninges (Fig. 5A). Hence they
are all potential candidates for regulating calvarial bone
development. In ch mutant tissues, expression patterns of
these Bmps were not altered (Fig. 5A), indicating that Foxc1
is not involved in the regulation of their expression. We next
asked whether BMPs act upstream of Foxc1, and whether
exogenous BMP regulates the expression of Foxc1 in cal-
varial mesenchyme. We placed BMP2-containing agarose
beads onto the calvarial mesenchyme of E15 wild type
explants, and cultured the explants for 48 h. We were unable
to show induction of Foxc1 around the BMP2-releasing
beads (data not shown). Foxc2 was not expressed in the
osteogenic head mesenchyme (Fig. 1), and no induction of
Foxc2 was observed in the mesenchyme surrounding BMP2
beads (data not shown): Bovine serum albumin (BSA)-
soaked beads were used as negative controls. BSA-soaked
beads showed no induction of Foxc1 or Foxc2 (data not
shown).
Kume et al. (1998) have shown that Foxc1-deficient cells
from sternal primordium have a reduced response to added
TGF or BMP2 in chondrogenic micromass cultures.
Hence, we next analyzed whether Foxc1 would affect the
response of calvarial mesenchyme to BMP signals. We have
shown previously that exogenous BMP2 and BMP4 both
induce Msx2 and Msx1 expression in calvarial mesenchyme
in vitro (Kim et al., 1998; Rice, 1999). We placed BMP2-
containing beads on the calvarial mesenchyme of wild type,
ch heterozygous, and ch null explants, and analyzed Msx2
expression after 48 h by in situ hybridization. Intense ex-
pression of Msx2 was seen around the beads in the wild type
(Fig. 5B) and heterozygous (data not shown) explants (n 
20). The induction was weaker in the mesenchyme near the
parietal bone margin. In contrast, BMP2 did not induce
Msx2 expression in ch mutant calvarial explants (n  5)
(Fig. 5B). Beads soaked in BMP7 had a similar effect as
BMP2 and induced the expression of Msx2 in wild type
calvarial explants but not in ch mutant explants (data not
shown). Exogenous BMP2 (Fig. 5B) and BMP7 (data not
shown) induced the expression of Alx4 in E15 wild type
calvarial explants but not in ch mutant explants. This indi-
cates that Alx4, like Msx2, is regulated by BMP and that this
regulation requires Foxc1. BSA-soaked control beads
showed no induction of Msx2 or Alx4 (data not shown).
The calvarial mesenchyme is thin and disorganized in ch
mutant animals (Kume et al., 1998), and it is possible that
the lack of Msx2 and Alx4 induction by BMP is not specific
but rather a general inability to respond to BMP signals. To
exclude this possibility, as well as to examine whether ch
mutant cells are generally unresponsive to BMP signals, we
analyzed whether BMP2 could induce the expression of
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Msx1 which is also regulated by BMP in calvarial mesen-
chyme (Kim et al., 1998). Msx1 was induced in ch mutant
explants by BMP2-containing beads in a similar manner to
wild type explants (Fig. 5B), indicating that the mesen-
chyme is indeed competent to respond to BMP and ex-
presses BMP receptors and other molecules needed for the
transduction of the BMP signal.
Taken together, our results suggest that Foxc1 is required
for the induction of Msx2 and Alx4 by BMP in the devel-
oping calvarium. Also, we show that BMP induces Alx4 in
calvarial mesenchyme.
Cell proliferation
We have shown previously that BMP4-containing beads
inducing Msx1 and Msx2 expression in calvarial sutures also
significantly increase the number of mesenchymal cells
(Kim et al., 1998). Furthermore, overexpression of Msx2
increases cell proliferation in the osteogenic fronts and
promotes growth of the parietal bones (Liu et al. 1999), and
conversely, lack of Msx2 decreases the number of BrdU-
positive cells at the osteogenic fronts during late embryonic
and postnatal calvarial development (Satokata et al. 2000).
To test whether the early proliferative pool of osteogenic
cells was affected in ch mutant mice, we assayed for BrdU
incorporation in the developing frontal bones. We found a
30% decrease in the number of BrdU-positive cells in the
calvarial mesenchyme of ch mutants in comparison to het-
erozygous littermates (no wild type embryos in the litters
collected) at E13 (Fig. 6A and B). At E15, the ch mutants
had 50% less BrdU-positive cells when compared with
heterozygous and wild type embryos (Fig. 6A and B). Due
to the small litter sizes, the wild type and heterozygous
embryos were combined for this analysis. The reduced
BrdU incorporation correlates with the lack of Msx2 and
Alx4 expression in the ch mutant calvarial mesenchyme
(Fig. 4I and S).
We performed TUNEL assay to test whether lack of
calvarial bone development was due to an increase in apo-
ptosis in calvarial mesenchyme. No difference was detected
between wild type and ch mutant littermates in the number
of apoptotic cells (data not shown).
Thus, these data suggest that Foxc1 regulates cell pro-
liferation in the osteoprogenitor cell population in the cal-
varial mesenchyme. We suggest that this regulation is me-
diated by Msx2 and also by Alx4.
Discussion
Foxc1 is expressed at early and late stages of bone
development
We have demonstrated that Foxc1 expression is turned
on early in both chondrogenic and osteogenic cell popula-
tions during craniofacial development. Interestingly, Foxc1
was expressed only at minimal levels in the osteogenic
condensations at E13 although the chondrogenic mesenchy-
mal condensations expressed it intensely. Osteogenic con-
densations at sutural bone margins did not express Foxc1
either. Later in development, Foxc1 was expressed in ma-
ture osteoblasts. The expression patterns are consistent with
a role for Foxc1 in the early specification of skeletal cell
lineages in the developing embryo. In mature osteoblasts,
Foxc1 may regulate osteoblast-specific extracellular matrix
production.
Studies of Foxc1 and Foxc2 double heterozygous and
compound heterozygous embryos have suggested that
Foxc1 cooperates with Foxc2 to activate target genes during
eye, heart, and kidney development, and during somitogen-
esis (Winnier et al., 1999; Smith et al., 2000; Kume et al.,
2001). These organs show extensively overlapping expres-
sion of Foxc1 and Foxc2. Here, we show that the expression
patterns of Foxc1 and Foxc2 overlap in the cartilaginous
skeleton in the head, in the mandible, meninges, and peri-
osteum, but not in the calvarial mesenchyme, indicating that
there is no interaction between Foxc1 and Foxc2 at this site,
and therefore functional redundancy is unlikely. This may
partly explain why the phenotype is more severe in calvarial
bones than in other bones in ch mutants.
Calvarial phenotype in ch animals
The ch mutant embryo displays a variety of skeletal
abnormalities. Both endochondrally developing bones, such
as vertebrae and the sternum, and intramembranously form-
ing bones are affected. Gru¨neberg (1943) suggested that the
primary defect was a cartilage anomaly and that the failure
of calvarial bone development was a mechanical conse-
quence of hydrocephalus in the mutants. However, later,
Gru¨neberg and Wickramaratne (1974) concluded that de-
fects in the subarachnoid space, which is part of the menin-
ges, caused the lack of bone development. These sugges-
tions were based on skeletal and histological analyses of ch
mutant mice. Kume et al. (1998) analyzed the Foxc1 null
mutant mice and proposed that Foxc1 is required for chon-
drogenesis and for meningeal development. The authors
favored Gru¨neberg’s original hypothesis that the absence of
intact skull bones is secondary to the hydrocephalus. This
was based on the finding that E11 dorsal head mesenchyme
micromass cultures derived from ch mutant embryos gave
rise to both cartilage and bone.
We examined the calvarial phenotype by skeletal stain-
ing, and show that a calvarial phenotype (a widened sagittal
suture at E17) is also seen in ch heterozygotes. We also
show that mechanical factors caused by intracranial pres-
sure are not likely to cause the lack of calvarial bone growth
in ch mutant animals. Calvarial bone development was not
rescued when explants of ch heterozygous or mutant ani-
mals were grown in organ culture where possible mechan-
ical effects of hydrocephalus are eliminated. These results,
together with the finding that Foxc1 is expressed in osteo-
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progenitor cells and mature osteoblasts, support the view
that the defect in calvarial bones in ch mutant mice is caused
by the lack of Foxc1 in calvarial mesenchyme.
Osteoblast lineage marker analysis by in situ hybridiza-
tion indicated that the calvarial mesenchyme is defective in
ch mutant animals. The expression of Msx2 and Alx4, two
transcription factors associated with calvarial bone devel-
opment and expressed in osteoprogenitor cells, was greatly
reduced in calvarial mesenchyme. In the calvarial bones of
ch mutant mice, osteoblast differentiation takes place only
within the initial mesenchymal condensations next to the
cranial base cartilages. In ch mutants, the Msx2 and Alx4
expression was limited to these condensations and to a
narrow region of surrounding calvarial mesenchyme.
Loss-of-function mutations in Msx2 or Alx4 cause simi-
lar calvarial phenotypes, i.e., defective calvarial bone de-
velopment resulting in parietal foramina both in humans and
mice due to deficient bone formation and the lack of closure
of calvarial sutures. The calvarial phenotype in ch mutant
embryos is much more severe than in either Msx2 or Alx4
null mice as the growth of calvarial bone is arrested after the
initial condensation stage. We suggest that Msx2 and Alx4
have similar functions in calvarial mesenchyme and that the
combined lack of their function produces the dramatic cal-
Fig. 5. Foxc1 is required for BMP induced expression of Msx2 and Alx4 in the developing calvarium. (A) Expression patterns of Bmp2, -4, and -7. All three
Bmps are expressed in the head mesenchyme, and Bmp4 and -7 also in the meningeal cell layers. No difference was detected between wild type and
Foxc1/ embryos. Scale bars are 200 m. (B) Transverse sections of calvarial explants cultured for 48 h with BMP2-containing agarose beads placed onto
the mesenchyme. In wild type explants, BMP2 has induced Msx2 and Alx4 expression in the mesenchyme around the bead. In Foxc1/ tissue, BMP2 has
not induced Msx2 and Alx4 expression. Endogenous Msx2 expression is seen in the periosteum of parietal bones both in wild type and Foxc1/ explants.
BMP2 beads have induced Msx1 expression both in wild type and Foxc1/ explants. Arrows indicate beads that have induced expression. Arrowheads
indicate the parietal bone margins. Beads were colored blue to aid visualization. Scale bars are 1 mm.
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varial phenotype in ch mutants. Interestingly, Alx4 expres-
sion, which unlike Msx2 was coexpressed with Foxc1 also
in the meninges, was absent from the meninges in ch mutant
embryos. This suggests that Foxc1 regulates Alx4 expres-
sion in both calvarial mesenchyme and meninges. The role
of the dura mater in the regulation of sutural ossification is
well established (Opperman et al., 1995; Kim et al., 1998;
Levine et al., 1998). Hence, Alx4 may have a dual function
in calvarial osteogenesis. It may control production of a
signal in the dura mater, regulating bone formation in the
neighboring calvarial mesenchyme and control the response
of the calvarial mesenchyme. Since calvarial bones are the
only bones that interact with dura mater during develop-
ment, the lack of meningeal signal may partly explain why
the calvarial bones are affected more severely than other
bones in ch mutants.
Foxc1 mediates BMP induction of Msx2 and Alx4
We show evidence that Foxc1 participates in BMP-in-
duced expression of Msx2 and Alx4 in the calvarial mesen-
chyme. Msx2 maintains early osteoprogenitor cell prolifer-
ation in sutures (Liu et al., 1999; Satokata et al., 2000), and
it regulates cell proliferation and differentiation in skin
(Jiang et al., 1999). We show that lack of Foxc1 is associ-
ated with a reduced amount of BrdU-positive cells in the
osteoprogenitor cell populated areas in calvarial mesen-
chyme. It would appear that Foxc1 is necessary for Msx2
and Alx4 expression only in proliferative calvarial mesen-
chyme. This we base on findings that, for instance, mesen-
chymal condensations and periosteum express Msx2 and
Alx4 in ch mutants. Both the condensations and periosteum
have no changes in their BrdU-positive cell counts. The
site-specific lack of proliferation in the osteoprogenitor cell
areas in calvarial mesenchyme may be responsible for the
lack of further calvarial bone development beyond the ru-
dimentary bones in ch mutants. Thus, our results indicate
that the initial calvarial bone formation is under different
controls than the subsequent progression of osteogenesis.
We suggest that Foxc1 plays an important part in the pro-
gression of calvarial bone development by regulating Msx2-
and Alx4-driven osteoblastic proliferation. Premature dif-
ferentiation would lead to a depletion of osteoprogenitor
cells and prevent further bone development. Other Fox
family members have been associated with cellular prolif-
eration. Foxe3 promotes proliferation of epithelial cells in
the developing lens (Blixt et al., 2000), Foxg1 regulates
proliferation in the telencephalic neuroepithelial cells (Xuan
et al., 1995), and Foxn1 in the epithelial cells of the hair
follicle (Brissette et al., 1996; Prowse et al., 1999).
We show that Foxc1 participates in the Bmp regulation
of Msx2 and Alx4. The source of the Bmp signal may be in
the mesenchyme or in the dura mater. Most of the affected
organs and structures in ch mutants form in a mesenchymal
environment and need inductive interactions with the sur-
rounding tissues during morphogenesis. Many of these in-
Fig. 6. Cell proliferation is reduced in Foxc1/ calvarial mesenchyme.
(A) BrdU incorporation in developing frontal bones. In Foxc1/ em-
bryos, cell proliferation is reduced in the osteogenic front regions (blue) in
calvarial mesenchyme but not in other areas of the developing bone such
as periosteum (red). Arrows point to the margins of the frontal bones. Scale
bars are 100 m. (B) Statistical analysis of the cell proliferation assay. Cell
proliferation was reduced 30% at E13 and 50% at E15 in Foxc1/. (C)
Schematic diagram of a molecular pathway involved in calvarial develop-
ment. The progression of calvarial bone growth beyond the condensation
sites needs proliferation of the osteoprogenitor cell population. We propose
that this is achieved by BMP-induction of Alx4 and Msx2 in osteogenic
mesenchyme and that this induction requires Foxc1. Interactions between
the dural cell layers and the mesenchyme may be needed.
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teractions involve Bmp signaling. Hence, it is possible that
mediating Bmp signaling may be a general function of
Foxc1 during development.
We have shown that Foxc1, Msx2, and Alx4 are coex-
pressed in calvarial mesenchyme, and that Foxc1 is required
for the induction of Msx2 and Alx4 expression by BMP in
this tissue (Fig. 6C). Since Foxc1 and Alx4 are also coex-
pressed in the meninges, which are affected in Foxc1 mu-
tants, it is possible that Foxc1 regulates calvarial bone
development not only by autocrine signaling but also in a
paracrine manner by influencing the production of a dural
signal involved in bone formation.
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